Message From NPC President Dan Leonard
True Cost of High Deductibles: Pain at the Rx Counter
As stakeholders and policymakers have traveled along the road to better value in health care, we may have forgotten that the end destination ought to be better patient outcomes. NPC President Dan Leonard considers the challenges facing patients, especially those enrolled in high-deductible health plans, in his latest commentary published in Chain Drug Review.
NPC Now: A Look At Our Latest Work
How Are Health Plans Using Patient Data to Improve Outcomes?
Health plans collect enormous amounts of data through electronic health records, administrative claims, mobile health devices and other sources. Is the data simply sitting on a shelf, or is it being used to shape care delivery, improve system efficiency, and achieve better health outcomes? A new NPC-Avalere white paper explores the answer.
NPC Submits Comments to FDA on Exchange of Clinical and Economic Information
In comments submitted to the Food and Drug Administration (FDA), NPC outlined ways to achieve a high-performing, value-based health care system through potential changes to how the exchange of clinical and economic information is regulated. Read our comments and related blog post.
How Can We Improve Oncology Quality Measurement in Accountable Care?
To determine whether or where there are gaps in oncology quality measurement, which can lead to missed opportunities to spot problems or improve care, NPC and Discern Health analyzed the current oncology quality measure landscape for 10 high-priority cancers. The analysis, published as a white paper, “Improving Oncology Quality Measurement in Accountable Care,” also examines cross-cutting measures that assess clinical processes and outcomes across more than one condition, including multiple types of cancer. View the white paper and our related peer-reviewed study. The archive of our recent webinar will be available online soon.
Research and Info You Need to Know
Incorporating What Matters to Patients in Quality Measures: A Discussion With NPAF’s Dr. Alan Balch
When it comes to quality measures, Dr. Alan Balch and the National Patient Advocate Foundation focus not only on the quality of a patient’s treatment paradigm, but also on what matters most to patients and how those factors inform their care and quality of life. We caught up with Dr. Balch to ask his thoughts about the impact of quality measures on patient care, particularly in the oncology space.
ICYMI: Articles of Note
- Kostova D, Fox J. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid. Medical Care. May 2017.
- Schur CL, Sutton JP. Physicians In Medicare ACOs Offer Mixed Views Of Model For Health Care Cost And Quality. Health Affairs. April 2017.
Events and Education
NPC @ AcademyHealth’s Health Datapalooza 2017
Join NPC at AcademyHealth’s Health Datapalooza conference on April 27-28 in Washington, D.C., where we will be at Booth 210 in the sponsor exhibition area.
NPC @ Asembia 2017 Specialty Pharmacy Summit
NPC is sponsoring the Asembia 2017 Specialty Pharmacy Summit, the largest specialty pharmacy conference in the country, in Las Vegas, Nevada, on April 30-May 3. Be sure to visit NPC at Booth 709 to learn about our latest research and activities.
NPC @ ISPOR 22nd Annual International Meeting
Join NPC at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting in Boston, Massachusetts, on May 20-24. NPC and its research staff will host an exhibition table (Booth 411) and participate in issue panels and workshops, including:
- Value Assessment Debate: Pluralistic Approach or Does One Size Fit All? (May 22, 11 a.m.)
- Will the Revised HHS Risk Adjustment Methodology Improve Accuracy in Predicting Costs for Diseases with Non-Uniform Patient Use of Specialty Therapeutics? (May 22, 1 p.m.)
- Actuarial and Health Economic Approaches to Assess Value: Speaking the Same Language or Need for Translation? (May 22, 2:15 p.m.)
- Is There Consistency in the Evidence That Payers Report Reviewing When Determining Drug Coverage? Should it be Consistent? (May 22, 3:45 p.m.)
- Health Care Economic Information: Considerations for Expanding Proactive Communications by Biopharmaceutical Manufacturers to Population Health Decision-makers (May 23, 3:45 p.m.)
HTAi 2017 Annual Meeting
Health Technology Assessment international (HTAi) will hold its annual meeting in Rome, Italy, on June 17-21. An abstract, "Are journal editors a barrier to publication of real-world evidence?" by Dr. Graff and Elizabeth Oehrlein of the University of Maryland, will be presented at the conference. For more information and to register to attend, visit the HTAi meeting website.